Scinovex
reviewTop 1% cited

Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome

Annual Review of Biochemistry · 2009 · Vol. 78(1) · pp. 477–513
Daniel Finley

Abstract

The proteasome is an intricate molecular machine, which serves to degrade proteins following their conjugation to ubiquitin. Substrates dock onto the proteasome at its 19-subunit regulatory particle via a diverse set of ubiquitin receptors and are then translocated into an internal chamber within the 28-subunit proteolytic core particle (CP), where they are hydrolyzed. Substrate is threaded into the CP through a narrow gated channel, and thus translocation requires unfolding of the substrate. Six distinct ATPases in the regulatory particle appear to form a ring complex and to drive unfolding as well as translocation. ATP-dependent, degradation-coupled deubiquitination of the substrate is required both for efficient substrate degradation and for preventing the degradation of the ubiquitin tag. However, the proteasome also contains deubiquitinating enzymes (DUBs) that can remove ubiquitin before substrate degradation initiates, thus allowing some substrates to dissociate from the proteasome and escape degradation. Here we examine the key elements of this molecular machine and how they cooperate in the processing of proteolytic substrates.

Ubiquitin and proteasome pathwaysAutophagy in Disease and TherapyPeptidase Inhibition and AnalysisUbiquitinProteasomeDeubiquitinating enzymeProtein subunitProtein degradationUbiquitin-conjugating enzymeProteolysisAAA proteinsChemistryATPase

MeSH terms

AnimalsHumansProteinsArabidopsisUbiquitinProteasome Endopeptidase Complex
Citations
1,764
FWCI
50.15
field-weighted impact
References
220
Percentile
100%
vs. same field & year
Citations per year
Cited by
The emerging complexity of protein ubiquitination
Biochemical Society Transactions · 2009 · 810 citations
The Ubiquitin Code
Annual Review of Biochemistry · 2012 · 3,574 citations
The N‐end rule pathway and regulation by proteolysis
Protein Science · 2011 · 721 citations
ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now?
Frontiers in Neuroscience · 2019 · 742 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.